blinatumomab
amgen
['blinatumomab']
#asco23 #asco2023 however, blinatumomab significantly improved dfs and os for the two thirds of patients with bm em relapse, establishing a new standard of care for this population.
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News